{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:02:23Z","timestamp":1791208943427,"version":"4.1.0"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007637","name":"COLCIENCIAS","doi-asserted-by":"crossref","award":["111551928905"],"award-info":[{"award-number":["111551928905"]}],"id":[{"id":"10.13039\/100007637","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CODI University of Antioquia"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.neuropharm.2015.01.027","type":"journal-article","created":{"date-parts":[[2015,2,7]],"date-time":"2015-02-07T12:04:19Z","timestamp":1423310659000},"page":"134-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":418,"special_numbering":"C","title":["The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice"],"prefix":"10.1016","volume":"93","author":[{"given":"Ang\u00e9lica Maria","family":"Sabogal-Gu\u00e1queta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Ignacio","family":"Mu\u00f1oz-Manco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose R.","family":"Ram\u00edrez-Pineda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisol","family":"Lamprea-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edison","family":"Osorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3814-4494","authenticated-orcid":false,"given":"Gloria Patricia","family":"Cardona-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2015.01.027_bib1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.physbeh.2014.06.008","article-title":"Quercetin protects the impairment of memory and anxiogenic-like behavior in rats exposed to cadmium: possible involvement of the acetylcholinesterase and Na(+),K(+)-ATPase activities","volume":"135","author":"Abdalla","year":"2014","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/HNP.0b013e31823c003a","article-title":"Investigation of the anxiolytic effects of naringenin, a component of mentha aquatica, in the male Sprague-Dawley rat","volume":"26","author":"Anderson","year":"2012","journal-title":"Holist. Nurs. Pract."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jnutbio.2008.03.002","article-title":"Protective effect of quercetin in primary neurons against Abeta(1-42): relevance to Alzheimer's disease","volume":"20","author":"Ansari","year":"2009","journal-title":"J.\u00a0Nutr. Biochem."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1054\/plef.2002.0387","article-title":"Downregulation of COX-2 and iNOS by amentoflavone and quercetin in A549 human lung adenocarcinoma cell line","volume":"66","author":"Banerjee","year":"2002","journal-title":"Prostagl. Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.neuropharm.2015.01.027_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2165\/00023210-200923040-00003","article-title":"Novel regimens and delivery systems in the pharmacological treatment of Alzheimer's disease","volume":"23","author":"Bassil","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2015.01.027_bib6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1742-2094-1-4","article-title":"Ginkgolide B inhibits the neurotoxicity of prions or amyloid-beta1-42","volume":"1","author":"Bate","year":"2004","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2015.01.027_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2014.02.007","article-title":"A\u00a0physiologically based kinetic (PBK) model describing plasma concentrations of quercetin and its metabolites in rats","author":"Boonpawa","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.exer.2010.03.016","article-title":"The effects of quercetin in cultured human RPE cells under oxidative stress and in Ccl2\/Cx3cr1 double deficient mice","volume":"91","author":"Cao","year":"2010","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.mcn.2003.10.008","article-title":"Estradiol inhibits GSK3 and regulates interaction of estrogen receptors, GSK3, and beta-catenin in the hippocampus","volume":"25","author":"Cardona-Gomez","year":"2004","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib10","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1248\/bpb.33.1534","article-title":"The natural flavonoid quercetin ameliorates cerulein-induced acute pancreatitis in mice","volume":"33","author":"Carvalho","year":"2010","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3389\/fnagi.2014.00243","article-title":"Long- and short-term CDK5 knockdown prevents spatial memory dysfunction and tau pathology of triple transgenic Alzheimer's mice","volume":"6","author":"Castro-Alvarez","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/cns.12189","article-title":"Quercetin improves behavioral deficiencies, restores astrocytes and microglia, and reduces serotonin metabolism in 3-nitropropionic acid-induced rat model of Huntington's Disease","volume":"20","author":"Chakraborty","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib13","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1021\/np060015w","article-title":"Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: extraction, biological analysis, and computational study","volume":"69","author":"Chimenti","year":"2006","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4068\/cmj.2014.50.2.45","article-title":"Effects of flavonoid compounds on beta-amyloid-peptide-induced neuronal death in cultured mouse cortical neurons","volume":"50","author":"Choi","year":"2014","journal-title":"Chonnam Med. J."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib15","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.neuron.2011.11.033","article-title":"Propagation of tau pathology in a model of early Alzheimer's disease","volume":"73","author":"de Calignon","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2015.01.027_bib16","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/jn\/134.3.552","article-title":"Quercetin metabolites downregulate cyclooxygenase-2 transcription in human lymphocytes ex\u00a0vivo but not in\u00a0vivo","volume":"134","author":"de Pascual-Teresa","year":"2004","journal-title":"J.\u00a0Nutr."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib17","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/npp.2011.191","article-title":"7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease","volume":"37","author":"Devi","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2015.01.027_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-009-0532-1","article-title":"Classification and basic pathology of Alzheimer disease","volume":"118","author":"Duyckaerts","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jnutbio.2009.01.014","article-title":"Mitochondria accumulate large amounts of quercetin: prevention of mitochondrial damage and release upon oxidation of the extramitochondrial fraction of the flavonoid","volume":"21","author":"Fiorani","year":"2010","journal-title":"J.\u00a0Nutr. Biochem."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib20","doi-asserted-by":"crossref","first-page":"16129","DOI":"10.1523\/JNEUROSCI.2323-12.2012","article-title":"Targeting astrocytes ameliorates neurologic changes in a mouse model of Alzheimer's disease","volume":"32","author":"Furman","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ejphar.2006.11.014","article-title":"The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang liver cells","volume":"557","author":"Garcia-Mediavilla","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3233\/JAD-122113","article-title":"Interaction of cinnamaldehyde and epicatechin with tau: implications of beneficial effects in modulating Alzheimer's disease pathogenesis","volume":"36","author":"George","year":"2013","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neubiorev.2006.07.007","article-title":"Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid","volume":"31","author":"Gimenez-Llort","year":"2007","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nbd.2011.07.005","article-title":"Morin attenuates tau hyperphosphorylation by inhibiting GSK3beta","volume":"44","author":"Gong","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib25","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1096\/fj.12-212118","article-title":"Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer's disease","volume":"27","author":"Ho","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib26","first-page":"454","article-title":"Effects of quercetin on the learning and memory ability of neonatal rats with hypoxic-ischemic brain damage","volume":"14","author":"Huang","year":"2012","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"10.1016\/j.neuropharm.2015.01.027_bib27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1582-4934.2008.00225.x","article-title":"Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention","volume":"12","author":"Iqbal","year":"2008","journal-title":"J.\u00a0Cell. Mol. Med."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrn2967","article-title":"Amyloid-beta and tau\u2013a toxic pas de deux in Alzheimer's disease","volume":"12","author":"Ittner","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-2094-2-23","article-title":"Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice","volume":"2","author":"Janelsins","year":"2005","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2015.01.027_bib30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11010-013-1675-x","article-title":"(-)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP\/PS1 mice by restoring IRS-1 signaling defects in the hippocampus","volume":"380","author":"Jia","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.brainres.2008.01.089","article-title":"Lack of robust protective effect of quercetin in two types of 6-hydroxydopamine-induced parkinsonian models in rats and dopaminergic cell cultures","volume":"1203","author":"Kaariainen","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib32","doi-asserted-by":"crossref","DOI":"10.1177\/0748233713504810","article-title":"Neuroprotective effect of quercetin against oxidative damage and neuronal apoptosis caused by cadmium in hippocampus","author":"Kanter","year":"2013","journal-title":"Toxicol. Ind. Health"},{"key":"10.1016\/j.neuropharm.2015.01.027_bib33","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.bcp.2011.09.002","article-title":"3-Hydroxy-2'-methoxy-6-methylflavone: a potent anxiolytic with a unique selectivity profile at GABA(A) receptor subtypes","volume":"82","author":"Karim","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib34","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/nn.3606","article-title":"Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease","volume":"17","author":"Khan","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.atherosclerosis.2011.04.023","article-title":"Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in\u00a0vitro and in\u00a0vivo models","volume":"218","author":"Kleemann","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.neuropharm.2015.01.027_bib36","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.neurobiolaging.2010.11.006","article-title":"Ultrastructural alterations of Alzheimer's disease paired helical filaments by grape seed-derived polyphenols","volume":"33","author":"Ksiezak-Reding","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2015.01.027_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2014.01.019","article-title":"Cur(Que)min: a neuroactive permutation of curcumin and quercetin for treating spinal cord injury","author":"Kumar","year":"2014","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.neuropharm.2015.01.027_bib38","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1124\/jpet.112.196147","article-title":"Proatherogenic macrophage activities are targeted by the flavonoid quercetin","volume":"343","author":"Lara-Guzman","year":"2012","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib39","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/j.1471-4159.2009.05908.x","article-title":"Curcumin, quercetin, and tBHQ modulate glutathione levels in astrocytes and neurons: importance of the glutamate cysteine ligase modifier subunit","volume":"108","author":"Lavoie","year":"2009","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib40","doi-asserted-by":"crossref","first-page":"R868","DOI":"10.1016\/j.cub.2007.08.005","article-title":"The amygdala","volume":"17","author":"LeDoux","year":"2007","journal-title":"Curr. Biol."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/nan.12002","article-title":"Review: experimental manipulations of microglia in mouse models of Alzheimer's pathology: activation reduces amyloid but hastens tau pathology","volume":"39","author":"Lee","year":"2013","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib42","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00702-004-0213-0","article-title":"Inhibition of microglial activation by the herbal flavonoid baicalein attenuates inflammation-mediated degeneration of dopaminergic neurons","volume":"112","author":"Li","year":"2005","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib43","doi-asserted-by":"crossref","first-page":"8370","DOI":"10.1523\/JNEUROSCI.21-21-08370.2001","article-title":"The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse","volume":"21","author":"Lim","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib44","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF00177912","article-title":"The use of a plus-maze to measure anxiety in the mouse","volume":"92","author":"Lister","year":"1987","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib45","doi-asserted-by":"crossref","first-page":"7630","DOI":"10.1021\/jf303387d","article-title":"Quercetin protects mouse brain against lead-induced neurotoxicity","volume":"61","author":"Liu","year":"2013","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib46","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.neuropharm.2012.11.018","article-title":"Quercetin protects against the Abeta(25-35)-induced amnesic injury: involvement of inactivation of rage-mediated pathway and conservation of the NVU","volume":"67","author":"Liu","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.01.027_bib47","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbadis.2011.09.004","article-title":"Natural substances and Alzheimer's disease: from preclinical studies to evidence based medicine","volume":"1822","author":"Mancuso","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2015.01.027_bib48","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/jn\/135.6.1359","article-title":"Quercetin attenuates nuclear factor-kappaB activation and nitric oxide production in interleukin-1beta-activated rat hepatocytes","volume":"135","author":"Martinez-Florez","year":"2005","journal-title":"J.\u00a0Nutr."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1471-2202-9-81","article-title":"Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer's disease-related pathologies in male triple-transgenic mice","volume":"9","author":"Mastrangelo","year":"2008","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib50","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fnint.2013.00059","article-title":"Inflammatory process in Alzheimer's Disease","volume":"7","author":"Meraz-Rios","year":"2013","journal-title":"Front. Integr. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib51","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00210-014-1008-y","article-title":"Quercetin mitigates Adriamycin-induced anxiety- and depression-like behaviors, immune dysfunction, and brain oxidative stress in rats","volume":"387","author":"Merzoug","year":"2014","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib52","first-page":"108","article-title":"Side effects of approved antidementives","volume":"21","author":"Mimica","year":"2009","journal-title":"Psychiatr. Danub"},{"key":"10.1016\/j.neuropharm.2015.01.027_bib53","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1248\/bpb.33.1932","article-title":"Biochemical characterization of epigallocatechin-3-gallate as an effective stimulator for the phosphorylation of its binding proteins by glycogen synthase kinase-3beta in\u00a0vitro","volume":"33","author":"Miyai","year":"2010","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib96","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3233\/JAD-131843","article-title":"Tau oligomers and fibrils induce activation of microglial cells","volume":"37","author":"Morales","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib54","first-page":"165021","article-title":"Microglia in Alzheimer brain: a neuropathological perspective","volume":"2012","author":"Mrak","year":"2012","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib55","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s11910-009-0054-1","article-title":"An update on treatment and prevention strategies for Alzheimer's disease","volume":"9","author":"Neugroschl","year":"2009","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib56","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neurobiolaging.2003.08.012","article-title":"Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease","volume":"24","author":"Oddo","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2015.01.027_bib57","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2015.01.027_bib97","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1517\/14740330903026944","article-title":"The multiple faces of quercetin in neuroprotection","volume":"8","author":"Ossola","year":"2009","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib58","doi-asserted-by":"crossref","first-page":"e14015","DOI":"10.1371\/journal.pone.0014015","article-title":"Formulation of a medical food cocktail for Alzheimer's disease: beneficial effects on cognition and neuropathology in a mouse model of the disease","volume":"5","author":"Parachikova","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2015.01.027_bib59","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.bbrc.2004.12.151","article-title":"Quercetin, a potent inhibitor against beta-catenin\/Tcf signaling in SW480 colon cancer cells","volume":"328","author":"Park","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib60","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000072357","article-title":"Protective effect of flavonoids against aging- and lipopolysaccharide-induced cognitive impairment in mice","volume":"69","author":"Patil","year":"2003","journal-title":"Pharmacology"},{"key":"10.1016\/j.neuropharm.2015.01.027_bib61","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2004"},{"key":"10.1016\/j.neuropharm.2015.01.027_bib62","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/jsfa.5697","article-title":"The flavonoid paradox: conjugation and deconjugation as key steps for the biological activity of flavonoids","volume":"92","author":"Perez-Vizcaino","year":"2012","journal-title":"J.\u00a0Sci. Food Agric."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib63","doi-asserted-by":"crossref","first-page":"13966","DOI":"10.1523\/JNEUROSCI.3637-10.2010","article-title":"Silencing of CDK5 reduces neurofibrillary tangles in transgenic alzheimer's mice","volume":"30","author":"Piedrahita","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib64","series-title":"Alzheimer's Disease International. World Alzheimer Report 2011. The Benefits of Early Diagnosis and Intervention","first-page":"2","year":"2011"},{"key":"10.1016\/j.neuropharm.2015.01.027_bib65","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nano.2007.12.001","article-title":"Anxiety and cognitive effects of quercetin liposomes in rats","volume":"4","author":"Priprem","year":"2008","journal-title":"Nanomedicine"},{"key":"10.1016\/j.neuropharm.2015.01.027_bib66","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/carcin\/bgl232","article-title":"Quercetin mediates preferential degradation of oncogenic Ras and causes autophagy in Ha-RAS-transformed human colon cells","volume":"28","author":"Psahoulia","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.neuropharm.2015.01.027_bib67","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib68","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrneurol.2011.2","article-title":"Epidemiology of Alzheimer disease","volume":"7","author":"Reitz","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib69","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.brainres.2008.02.107","article-title":"Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice","volume":"1214","author":"Rezai-Zadeh","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib70","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neulet.2013.06.036","article-title":"Increased densities of resting and activated microglia in the dentate gyrus follow senile plaque formation in the CA1 subfield of the hippocampus in the triple transgenic model of Alzheimer's disease","volume":"552","author":"Rodriguez","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib71","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-3-642-38007-5_11","article-title":"Quercetin: a pleiotropic kinase inhibitor against Cancer","volume":"159","author":"Russo","year":"2014","journal-title":"Cancer Treat. Res."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib72","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bcp.2011.08.010","article-title":"The flavonoid quercetin in disease prevention and therapy: facts and fancies","volume":"83","author":"Russo","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib73","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.brainresbull.2007.01.016","article-title":"Modulation of interleukin-1beta mediated inflammatory response in human astrocytes by flavonoids: implications in neuroprotection","volume":"73","author":"Sharma","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib74","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1016\/j.bmcl.2013.07.020","article-title":"Potential neuroprotective flavonoid-based inhibitors of CDK5\/p25 from Rhus parviflora","volume":"23","author":"Shrestha","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib75","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/35067589","article-title":"Acetylcholinesterase\u2013new roles for an old actor","volume":"2","author":"Soreq","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib76","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1039\/b800422f","article-title":"The impact of flavonoids on memory: physiological and molecular considerations","volume":"38","author":"Spencer","year":"2009","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib77","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.brainres.2010.06.011","article-title":"Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 2. Behavioral and cognitive changes","volume":"1348","author":"Sterniczuk","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib78","series-title":"X-Plo-Rat 2005 1.1.0","author":"Taverna-Chaim","year":"2008"},{"key":"10.1016\/j.neuropharm.2015.01.027_bib79","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1039\/C0FO00106F","article-title":"Conjugated quercetin glucuronides as bioactive metabolites and precursors of aglycone in\u00a0vivo","volume":"2","author":"Terao","year":"2011","journal-title":"Food Funct."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib80","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1365-2990.2011.01232.x","article-title":"Expression of glia maturation factor in neuropathological lesions of Alzheimer's disease","volume":"38","author":"Thangavel","year":"2012","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib81","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3233\/JAD-2012-121408","article-title":"Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease","volume":"33","author":"Velayudhan","year":"2013","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib82","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11481-008-9142-2","article-title":"Imaging microglial activation during neuroinflammation and Alzheimer's disease","volume":"4","author":"Venneti","year":"2009","journal-title":"J.\u00a0Neuroimmune Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib83","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jnutbio.2011.03.017","article-title":"Route of administration determines the anxiolytic activity of the flavonols kaempferol, quercetin and myricetin\u2013are they prodrugs?","volume":"23","author":"Vissiennon","year":"2012","journal-title":"J.\u00a0Nutr. Biochem."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib84","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nprot.2007.44","article-title":"The use of the elevated plus maze as an assay of anxiety-related behavior in rodents","volume":"2","author":"Walf","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib85","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1037\/0033-2909.83.3.482","article-title":"The open-field test: a critical review","volume":"83","author":"Walsh","year":"1976","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib86","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s11064-014-1343-x","article-title":"Effects of long-term treatment with quercetin on cognition and mitochondrial function in a mouse model of Alzheimer's disease","volume":"39","author":"Wang","year":"2014","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib87","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1096\/fj.06-6281com","article-title":"Moderate consumption of cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease","volume":"20","author":"Wang","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib88","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00001756-200502280-00013","article-title":"Genistein protects dopaminergic neurons by inhibiting microglial activation","volume":"16","author":"Wang","year":"2005","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2015.01.027_bib89","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.freeradbiomed.2004.01.001","article-title":"Flavonoids: antioxidants or signalling molecules?","volume":"36","author":"Williams","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib90","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/jnr.21998","article-title":"NMDA receptor-dependent signaling pathways that underlie amyloid beta-protein disruption of LTP in the hippocampus","volume":"87","author":"Yamin","year":"2009","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib91","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.ejrad.2013.03.019","article-title":"Decreased functional connectivity of the amygdala in Alzheimer's disease revealed by resting-state fMRI","volume":"82","author":"Yao","year":"2013","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib92","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1007\/s11064-012-0871-5","article-title":"Quercetin attenuates cell apoptosis in focal cerebral ischemia rat brain via activation of BDNF-TrkB-PI3K\/Akt signaling pathway","volume":"37","author":"Yao","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib93","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ptr.2902","article-title":"Quercetin improves cognitive deficits in rats with chronic cerebral ischemia and inhibits voltage-dependent sodium channels in hippocampal CA1 pyramidal neurons","volume":"24","author":"Yao","year":"2010","journal-title":"Phytother. Res."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib98","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2015.01.027_bib94","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.freeradbiomed.2004.08.002","article-title":"Flavonoids and the brain: interactions at the blood-brain barrier and their physiological effects on the central nervous system","volume":"37","author":"Youdim","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2015.01.027_bib95","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1021\/np034011s","article-title":"Effects of natural flavones and flavonols on the kinase activity of Cdk5","volume":"67","author":"Zapata-Torres","year":"2004","journal-title":"J.\u00a0Nat. Prod."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081500043X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081500043X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T14:49:47Z","timestamp":1566312587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839081500043X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":98,"alternative-id":["S002839081500043X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.01.027","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.01.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}